GOSS

Gossamer Bio, Inc.NASDAQHealthcare

$0.37+1.37%ClosedMarket Cap: $86.8M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-23	Cantor Fitzgerald	—	Neutral	—
2026-03-06	HC Wainwright & Co.	—	Buy	—
2026-03-05	Oppenheimer	—	Outperform	—
2026-02-24	Wedbush	—	Neutral	—
2026-02-24	Leerink Partners	—	Market Perform	—
2026-02-24	Barclays	—	Underweight	—
2026-01-22	HC Wainwright & Co.	—	Buy	—
2025-09-11	Cantor Fitzgerald	—	Overweight	—
2025-09-10	UBS	—	Buy	—
2025-08-06	Wedbush	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.16	$57.2M	6
Sun Dec 31	$0.05	$133.1M	6
Mon Dec 31	$0.17	$234.4M	4
Tue Dec 31	$0.34	$362.1M	2

GOSS | Gossamer Bio, Inc. Analyst Ratings & Price Target - InvestLog